The different datasets are contributing to the support for EU regulation on nanomaterials , anticipation of regulatory needs for nanomedicines. The data derive from vairous sources: 3 surveys, proteomics data, transcriptomics data, literature review data, terminology data (processed) and experiment data produced in the frame of institutional and exploratory projects.
